| BIOGEN INC. DL -,0005 | 264.80 / -0.95% |
| Date/Time | 01/27 / 08:02 |
| Chg. / Chg.(%) | -2.55 / -0.95% |
| Bid | - |
| Ask | - |
| Open | 264.80 |
| Previous Close | 267.35 |
| High | 264.80 |
| Low | 264.80 |
| Volume [EUR] | 0.00 |
| Volume [Units] | 0 |
| Price fixings | 1 |
| ISIN | US09062X1037 |
| Security | IDP |
| Exchange | Hamburg |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 290.0800 |  |
894,079 |
| IEX | 290.00 | |
39,710 |
| Cboe US | 290.05 | |
38,905 |
| TradeGate | 267.250 | |
516 |
| Xetra | 270.80 |  |
100 |
| gettex | 268.450 | |
48 |
| Vienna Globa.. | 270.80 | |
39 |
| Quotrix | 270.2000 | |
19 |
| Frankfurt | 268.3500 | |
10 |
| München | 264.80 | |
0 |
| Hamburg | 264.80 | |
0 |
| Düsseldorf | 269.05 | |
0 |
| Berlin | 268.25 | |
0 |
| Hannover | 264.80 | |
0 |
| Lang & Schwa.. | 266.550 | |
|
| Stuttgart | 268.750 | |
News
- FDA approves drug for early Alzheimer's treatment
01/06/2023 / 21:10 - TeleTrader - Wall Street extends losses on rate talks, China unrest
11/28/2022 / 19:15 - TeleTrader - Biogen falls 5% after death in Alzheimer's drug trial
11/28/2022 / 13:40 - TeleTrader - Biogen's EPS sees annual jump of 253% in Q3
10/25/2022 / 13:05 - TeleTrader - Biogen's Q2 EPS soar by 142.14% to $7.24 per share
07/20/2022 / 13:01 - TeleTrader
Real-time